Mersana Therapeutics Inc [NASDAQ: MRSN] loss -44.62% or -0.58 points to close at $0.72 with a heavy trading volume of 57727103 shares.
The daily chart for MRSN points out that the company has recorded -64.53% loss over the past six months.
If we look at the average trading volume of 1.24M shares, MRSN reached to a volume of 57727103 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Mersana Therapeutics Inc [MRSN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MRSN shares is $5.38 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MRSN stock is a recommendation set at 1.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Citigroup have made an estimate for Mersana Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 15, 2024. The new note on the price target was released on March 19, 2024, representing the official price target for Mersana Therapeutics Inc stock. Previously, the target price had yet another raise from $2 to $7, while Wedbush kept a Outperform rating on MRSN stock.
The Average True Range (ATR) for Mersana Therapeutics Inc is set at 0.22, with the Price to Sales ratio for MRSN stock in the period of the last 12 months amounting to 2.55. The Price to Book ratio for the last quarter was 84.31, with the Price to Cash per share for the same quarter was set at 1.26.
Trading performance analysis for MRSN stock
Mersana Therapeutics Inc [MRSN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -48.57. With this latest performance, MRSN shares dropped by -71.76% in over the last four-week period, additionally sinking by -64.53% over the last 6 months – not to mention a drop of -77.71% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MRSN stock in for the last two-week period is set at 20.70, with the RSI for the last a single of trading hit 13.01, and the three-weeks RSI is set at 26.83 for Mersana Therapeutics Inc [MRSN]. The present Moving Average for the last 50 days of trading for this stock 1.9918, while it was recorded at 1.2280 for the last single week of trading, and 2.2417 for the last 200 days.
Mersana Therapeutics Inc [MRSN]: A deeper dive into fundamental analysis
Mersana Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.35 and a Current Ratio set at 2.35.
An analysis of Institutional ownership at Mersana Therapeutics Inc [MRSN]
There are presently around $102.16%, or 103.55%% of MRSN stock, in the hands of institutional investors. The top three institutional holders of MRSN stocks are: ECOR1 CAPITAL, LLC with ownership of 19.36 million shares, which is approximately 15.9479%. VR ADVISER, LLC, holding 11.33 million shares of the stock with an approximate value of $$22.77 million in MRSN stocks shares; and VR ADVISER, LLC, currently with $$19.15 million in MRSN stock with ownership which is approximately 7.8453%.
